SCHEMBL3289965

SCHEMBL3289965

CCCC1(CCC)c2cc(-c3nc4cc(C)ccc4o3)ccc2-c2cc(O)c(-c3nc4cc(C)ccc4o3)cc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 12/20 0.49
RAB9A P51151 12/20 0.49
SMN1; SMN2 Q16637 12/20 0.49
ALDH1A1 P00352 11/20 0.49
NPC1 O15118 10/20 0.49
HPGD P15428 9/20 0.49
TP53 P04637 9/20 0.49
HSD17B10 Q99714 8/20 0.49
CASP3 P42574 4/20 0.46
SENP8 Q96LD8 4/20 0.46
SENP7 Q9BQF6 4/20 0.46
SENP6 Q9GZR1 4/20 0.46
MAPT P10636 7/20 0.46
NFKB1 P19838 4/20 0.46
NFKB2 Q00653 4/20 0.46
RELA Q04206 4/20 0.46
ALOX5 P09917 1/20 0.45
POLB P06746 2/20 0.44
MAPK1 P28482 2/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29723524 1.00 KDM4E (0.49) KDM4ERAB9ASMN1; SMN2ALDH1A1NPC1
SCHEMBL3291037 0.87 ALOX5 (0.55) KDM4ERAB9ASMN1; SMN2ALDH1A1NPC1
SCHEMBL13327382 0.81 MAPT (0.53) KDM4ERAB9ASMN1; SMN2ALDH1A1NPC1
SCHEMBL13327367 0.78 MAPT (0.43) KDM4ERAB9ASMN1; SMN2ALDH1A1NPC1
SCHEMBL13327380 0.77 RAB9A (0.38) KDM4ERAB9ASMN1; SMN2ALDH1A1NPC1
SCHEMBL13327377 0.74 RAB9A (0.42) KDM4ERAB9ASMN1; SMN2ALDH1A1NPC1
SCHEMBL28380716 0.74 KDM4E (0.45) KDM4ERAB9ASMN1; SMN2ALDH1A1NPC1
SCHEMBL10045379 0.72 KDM4E (0.53) KDM4ERAB9ASMN1; SMN2ALDH1A1NPC1
SCHEMBL804301 0.71 KDM6B (0.50) KDM4ERAB9ASMN1; SMN2ALDH1A1NPC1
SCHEMBL14947173 0.70 ALDH1A1 (0.96) KDM4ERAB9ASMN1; SMN2ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838682-B1 COMPOUNDS THAT ABSORB ULTRAVIOLET LIGHT, METHODS OF THEIR PREPARATION AND OPTICAL LENSES CONTAINING THEM ESSILOR INT (FR) 2013-09-25 EP claimed
US-7713452-B2 Compounds that absorb ultraviolet light, methods of their preparation and optical lenses containing them ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) 2010-05-11 US claimed
US-20080064880-A1 Compounds That Absorb Ultraviolet Light, Methods of Their Preparation and Optical Lenses Containing Them ESSILOR INTERNATIONAL COMPAGNIE GENERALE D' OPTIQUE (FR) 2008-03-13 US claimed
EP-1838682-A2 COMPOUNDS THAT ABSORB ULTRAVIOLET LIGHT, METHODS OF THEIR PREPARATION AND OPTICAL LENSES CONTAINING THEM ESSILOR INTERNATIONAL Compagnie Générale d'Optique (FR) 2007-10-03 EP claimed
WO-2006069811-A2 COMPOUNDS THAT ABSORB ULTRAVIOLET LIGHT, METHODS OF THEIR PREPARATION AND OPTICAL LENSES CONTAINING THEM ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) 2006-07-06 WO claimed
EP-4530054-A1 OPTICAL ARTICLE COMPRISING A SUBSTRATE FOR MYOPIA CONTROL WITH EMBEDDED NANOPARTICLES Essilor International (FR) 2025-04-02 EP disclosed
EP-3665514-B1 OPTICAL ARTICLE COMPRISING A SUBSTRATE WITH EMBEDDED PARTICLES FOR LIGHT TRANSMISSION ENHANCEMENT ESSILOR INT (FR) 2024-10-02 EP disclosed
EP-3632950-B1 STORAGE-STABLE HEAT-CURABLE HYBRID EPOXY FUNCTIONAL COMPOSITION AND TRANSPARENT HEAT-CURED COATINGS PREPARED THEREFROM ESSILOR INT (FR) 2024-07-17 EP disclosed
EP-3665515-B1 OPTICAL ARTICLE COMPRISING A SUBSTRATE WITH EMBEDDED PARTICLES FOR ABRASION AND/OR SCRATCH RESISTANCE ENHANCEMENT ESSILOR INT (FR) 2024-01-17 EP disclosed
US-11852784-B2 Optical article comprising a substrate with embedded particles for light transmission enhancement ESSILOR INTERNATIONAL (FR) 2023-12-26 US disclosed
EP-3327091-B1 EPOXY FUNCTIONAL COMPOSITION PROTECTING DYES FROM PHOTO-DEGRADATION AND CURED COATINGS PREPARED THEREFROM ESSILOR INT (FR) 2023-01-18 EP disclosed
EP-3318920-B1 NEAR INFRARED LIGHT-CUTTING OPTICAL ARTICLES WITH LOW RESIDUAL COLOR ESSILOR INT (FR) 2022-07-06 EP disclosed
US-7713452-B2 Compounds that absorb ultraviolet light, methods of their preparation and optical lenses containing them ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) 2010-05-11 US disclosed
US-7713452-B2 Compounds that absorb ultraviolet light, methods of their preparation and optical lenses containing them ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) 2010-05-11 US disclosed
US-7713452-B2 Compounds that absorb ultraviolet light, methods of their preparation and optical lenses containing them ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) 2010-05-11 US disclosed
US-20080064880-A1 Compounds That Absorb Ultraviolet Light, Methods of Their Preparation and Optical Lenses Containing Them ESSILOR INTERNATIONAL COMPAGNIE GENERALE D' OPTIQUE (FR) 2008-03-13 US disclosed
US-20080064880-A1 Compounds That Absorb Ultraviolet Light, Methods of Their Preparation and Optical Lenses Containing Them ESSILOR INTERNATIONAL COMPAGNIE GENERALE D' OPTIQUE (FR) 2008-03-13 US disclosed
US-20080064880-A1 Compounds That Absorb Ultraviolet Light, Methods of Their Preparation and Optical Lenses Containing Them ESSILOR INTERNATIONAL COMPAGNIE GENERALE D' OPTIQUE (FR) 2008-03-13 US disclosed
EP-1838682-A2 COMPOUNDS THAT ABSORB ULTRAVIOLET LIGHT, METHODS OF THEIR PREPARATION AND OPTICAL LENSES CONTAINING THEM ESSILOR INTERNATIONAL Compagnie Générale d'Optique (FR) 2007-10-03 EP disclosed
WO-2006069811-A2 COMPOUNDS THAT ABSORB ULTRAVIOLET LIGHT, METHODS OF THEIR PREPARATION AND OPTICAL LENSES CONTAINING THEM ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) 2006-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064880-A1 Compounds That Absorb Ultraviolet Light, Methods of Their Preparation and Optical Lenses Containing Them CRYAB, CRYAA, CRYZ KDM4E 805/4885RAB9A 2410/4885SMN1; SMN2 4736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.